资讯

Aurobindo Pharma arm gets U.S. FDA nod for generic of BMS’ cancer drug
Aurobindo Pharma's Eugia Pharma approved to manufacture Dasatinib Tablets, a bioequivalent to Bristol-Myers Squibb's Sprycel, ...
IndiaInfoline4 天
Aurobindo Pharma Gets USFDA Nod for Leukemia Drug Dasatinib
Dasatinib Tablets US market size was approximately $1.8 billion for the 12 months ended February 2025, based on industry data ...
Medical Dialogues4 天
Aurobindo Pharma arm Eugia Pharma Specialities gets USFDA nod for cancer drug
Hyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Eugia PharmaSpecialities Limited, has ...
Aurobindo Pharma in focus: Why has the stock gained 3% in trade today?
The up move in the stock came after the company arm Eugia Pharma Specialities, received final approval from USFDA to ...
CNBCTV184 天
Aurobindo Pharma shares gain nearly 3% after getting USFDA nod for leukemia drug
Aurobindo Pharma's shares rose nearly 3% after its subsidiary, Eugia Pharma, received USFDA approval to market Dasatinib ...
Aurobindo Pharma arm Eugia gets USFDA nod for Dasatinib tablets, eyes $1.8 billion market
Eugia Pharma, a subsidiary of Aurobindo Pharma, has secured final USFDA approval for manufacturing and marketing Dasatinib ...